Effectiveness and safety of tofacitinib for ulcerative colitis: two‐year results of the ICC Registry
Tessa Straatmijer(Leiden University Medical Center), Marjolijn Duijvestein(Amsterdam University Medical Centers), Adriaan A. van Bodegraven(Maastricht University Medical Centre), Mark Löwenberg(Amsterdam University Medical Centers), Bas Oldenburg(University Medical Center Utrecht), Nidhi Srivastava, Marieke Pierik(Maastricht University Medical Centre), Annemarie C. de Vries(Erasmus MC), Zlatan Mujagic(Maastricht University Medical Centre), Alexander Bodelier(Amphia Ziekenhuis), Andrea E. van der Meulen‐de Jong(Leiden University Medical Center), Cyriel Y. Ponsioen(Amsterdam UMC Location University of Amsterdam), Vince Biemans(Radboud University Nijmegen), Marijn C. Visschedijk(University Medical Center Groningen), Gerard Dijkstra(University Medical Center Groningen), Tessa E H Römkens(Jeroen Bosch Ziekenhuis), Rachel West(Sint Franciscus Gasthuis), Nanne K.H. de Boer, Jildou Hoekstra(Amphia Ziekenhuis), Fiona D M van Schaik(University Medical Center Utrecht)
Cited by 28
Related Papers
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity
|Science|2016|2k
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases
|Nature Genetics|2019|1.6k